GB1325797A
(en)
|
1970-09-24 |
1973-08-08 |
Upjohn Co |
Medicines comprising cytidine derivatives
|
GB1386334A
(en)
|
1972-09-22 |
1975-03-05 |
Kohjin Co |
2,2-cyclocytidine derivatives
|
DE2456547A1
(de)
|
1973-11-29 |
1975-08-14 |
Kohjin Co |
N hoch 4 -substituierte 2,2'-cyclocytidin-verbindungen
|
US4096324A
(en)
|
1975-07-07 |
1978-06-20 |
The Upjohn Company |
Cytidine nucleoside compound
|
US5470838A
(en)
|
1987-10-28 |
1995-11-28 |
Pro-Neuron, Inc. |
Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
|
US5736531A
(en)
|
1987-10-28 |
1998-04-07 |
Pro-Neuron, Inc. |
Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
|
EP0476071A4
(en)
|
1989-06-05 |
1992-11-04 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides and methods for preparing the same
|
AU9094991A
(en)
|
1990-11-23 |
1992-06-25 |
Gilead Sciences, Inc. |
Triplex-forming oligomers containing modified bases
|
FI105556B
(fi)
|
1991-09-30 |
2000-09-15 |
Sankyo Co |
Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
|
ATE151432T1
(de)
|
1991-10-11 |
1997-04-15 |
Acad Of Science Czech Republic |
Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate
|
EP1256589A3
(en)
|
1991-11-26 |
2003-09-17 |
Isis Pharmaceuticals, Inc. |
Oligomers containing modified pyrimidines
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
AU6632094A
(en)
|
1993-04-19 |
1994-11-08 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
US5349947A
(en)
|
1993-07-15 |
1994-09-27 |
Newhouse Michael T |
Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
|
WO1995007920A1
(en)
|
1993-09-17 |
1995-03-23 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
KR100386685B1
(ko)
|
1993-09-17 |
2003-12-31 |
길리애드 사이언시즈, 인코포레이티드 |
뉴클레오타이드동족체류
|
CN100409844C
(zh)
|
1995-02-27 |
2008-08-13 |
吉里德科学公司 |
神经氨酸苷酶抑制剂
|
US6043358A
(en)
|
1995-11-01 |
2000-03-28 |
Merck & Co., Inc. |
Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
|
JP2001502690A
(ja)
|
1996-10-21 |
2001-02-27 |
ギリアード サイエンシーズ,インコーポレイテッド |
ピペリジン化合物
|
GB9718913D0
(en)
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
CN1315862C
(zh)
|
2000-05-26 |
2007-05-16 |
艾登尼科斯(开曼)有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
CA2743451A1
(en)
|
2000-10-18 |
2002-04-25 |
Pharmasset, Inc. |
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
CA2426196A1
(en)
|
2000-10-18 |
2002-04-25 |
Lieven Stuyver |
Simultaneous quantification of nucleic acids in diseased cells
|
PT2251015E
(pt)
|
2000-10-18 |
2013-04-15 |
Gilead Pharmasset Llc |
Nucleosídeos modificados para o tratamento de infeções virais e de proliferação celular anormal
|
HUP0400732A3
(en)
|
2001-04-30 |
2007-05-29 |
Trommsdorff Arzneimittel |
Pharmaceutically active uridine esters
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US7049303B2
(en)
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
US20050239054A1
(en)
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
JP4942915B2
(ja)
|
2002-04-26 |
2012-05-30 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivプロテアーゼ阻害剤化合物のホスホネートアナログの細胞蓄積
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
JP4806187B2
(ja)
|
2002-07-15 |
2011-11-02 |
ギリード・サイエンシズ・インコーポレーテッド |
B型肝炎ウイルスの治療のためのl−fmauとの併用療法
|
JPWO2004024185A1
(ja)
|
2002-09-11 |
2006-01-26 |
道男 石橋 |
医薬または化粧料
|
US20040194155A1
(en)
|
2002-10-01 |
2004-09-30 |
Gilead Sciences, Inc. |
HBV mutations associated with reduced susceptibility to adefovir
|
US20040157804A1
(en)
|
2002-10-16 |
2004-08-12 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
US20040171860A1
(en)
|
2002-11-12 |
2004-09-02 |
Hong Zhao |
Novel acylating reagents
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
EP1581496A4
(en)
|
2002-12-02 |
2008-04-23 |
Gilead Sciences Inc |
2-SUBSTITUTED 3-PROPENAMIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
|
PL378368A1
(pl)
|
2003-01-14 |
2006-04-03 |
Gilead Sciences, Inc. |
Kompozycje i sposoby wykorzystywane w skojarzonej terapii przeciwwirusowej
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
MXPA05011294A
(es)
|
2003-04-25 |
2006-03-15 |
Gilead Sciences Inc |
Compuestos de fosfonato anti-inflamatorios.
|
ATE490788T1
(de)
|
2003-04-25 |
2010-12-15 |
Gilead Sciences Inc |
Antivirale phosphonate analoge
|
JP2007500727A
(ja)
|
2003-07-30 |
2007-01-18 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス処置のための核酸塩基ホスホネートアナログ
|
AU2004274493A1
(en)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
RU2264409C2
(ru)
|
2003-10-01 |
2005-11-20 |
Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") |
2`-амино-2`-дезоксинуклеозиды - ингибиторы репродукции вирусов кори и марбург
|
EP1680512A1
(en)
|
2003-10-24 |
2006-07-19 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
JP2007509994A
(ja)
|
2003-11-03 |
2007-04-19 |
コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
アシルリボヌクレオシドおよびアシルデオキシリボヌクレオシド
|
JP4970048B2
(ja)
|
2003-12-22 |
2012-07-04 |
カトリーケ・ウニフェルジテイト・ルーベン・カー・イュー・ルーベン・アール・アンド・ディ |
イミダゾ[4,5−c]ピリジン化合物および抗ウイルス治療の方法
|
JP2007515495A
(ja)
|
2003-12-22 |
2007-06-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
4’−置換カルボビル誘導体およびアバカビル誘導体ならびにhivおよびhcv抗ウイルス活性を有する関連化合物
|
DE602004028763D1
(de)
|
2003-12-30 |
2010-09-30 |
Gilead Sciences Inc |
Te zur behandlung von virenerkrankungen
|
KR20060124701A
(ko)
|
2004-01-12 |
2006-12-05 |
길리애드 사이언시즈, 인코포레이티드 |
피리미딜 포스포네이트 항바이러스성 화합물 및 그의 사용방법
|
WO2005072748A1
(en)
|
2004-01-21 |
2005-08-11 |
Gilead Sciences, Inc. |
Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
|
ES2315922T3
(es)
|
2004-04-14 |
2009-04-01 |
Gilead Sciences, Inc. |
Analogos de fosfonato de compuestos inhibidores de la integrasa del vih.
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
CA2571984C
(en)
|
2004-07-16 |
2012-04-10 |
Gilead Sciences, Inc. |
Antiviral compounds
|
TR201906416T4
(tr)
|
2004-07-27 |
2019-05-21 |
Gilead Sciences Inc |
Hiv inhibitörü bileşiklerin fosfonat analogları.
|
JP5014129B2
(ja)
|
2004-07-27 |
2012-08-29 |
ギリアード サイエンシーズ, インコーポレイテッド |
イミダゾ[4,5−d]ピリミジン、それらの使用および調製方法
|
DE102004051804A1
(de)
*
|
2004-10-21 |
2006-04-27 |
Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) |
Beta-L-N4-Hydroxycytosin-Desoxynucleoside und ihre Verwendung als pharmazeutische Mittel zur Prophylaxe oder Therapie von viralen Erkrankungen
|
EP1809277A2
(en)
|
2004-10-26 |
2007-07-25 |
Inc. Gilead Sciences |
Phosphonate derivatives of mycophenolic acid
|
PL1841765T3
(pl)
|
2004-12-21 |
2009-08-31 |
Gilead Sciences Inc |
Związek imidazo[4,5-c]pirydyny i sposób leczenia przeciwwirusowego
|
WO2006091905A1
(en)
|
2005-02-25 |
2006-08-31 |
Gilead Sciences, Inc. |
Bicyclo (3.1.0) hexane derivatives as antiviral compounds
|
WO2006125048A2
(en)
|
2005-05-16 |
2006-11-23 |
Gilead Sciences, Inc. |
Hiv-integrase inhibitor compounds
|
EP2581440B1
(en)
|
2005-06-08 |
2016-03-16 |
The University of North Carolina At Chapel Hill |
Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
|
TWI389908B
(zh)
|
2005-07-14 |
2013-03-21 |
Gilead Sciences Inc |
抗病毒化合物類
|
TW200738742A
(en)
|
2005-07-14 |
2007-10-16 |
Gilead Sciences Inc |
Antiviral compounds
|
WO2007014174A2
(en)
|
2005-07-25 |
2007-02-01 |
Gilead Sciences, Inc. |
Drug-resistant mutants of hepatitis c virus
|
US20080076740A1
(en)
|
2005-07-27 |
2008-03-27 |
Gilead Sciences, Inc. |
Antiviral compounds
|
EP1919924A2
(en)
|
2005-08-16 |
2008-05-14 |
Irm, Llc |
Compounds and compositions as protein kinase inhibitors
|
KR20080036655A
(ko)
|
2005-09-22 |
2008-04-28 |
에프. 호프만-라 로슈 아게 |
뉴클레오사이드의 선택적인 o-아실화
|
KR20140082858A
(ko)
|
2005-12-30 |
2014-07-02 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 인테그라제 억제제의 약동학을 개선하기 위한 방법
|
US20110065631A1
(en)
|
2006-03-29 |
2011-03-17 |
Gilead Sciences, Inc |
Process for preparation of hiv protease inhibitors
|
US20090318456A1
(en)
|
2006-07-06 |
2009-12-24 |
Gilead Sciences, Inc. |
Substituted pteridines for the treatment and prevention of viral infections
|
ES2339298T3
(es)
|
2006-07-07 |
2010-05-18 |
Gilead Sciences, Inc. |
Compuesto de piridazina novedoso y uso del mismo.
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
PT2038290E
(pt)
|
2006-07-07 |
2013-12-10 |
Gilead Sciences Inc |
Moduladores de receptor do tipo toll 7
|
ES2796275T3
(es)
|
2006-07-07 |
2020-11-26 |
Gilead Sciences Inc |
Moduladores de propiedades farmacocinéticas de agentes terapéuticos
|
US8673929B2
(en)
|
2006-07-20 |
2014-03-18 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
WO2008009078A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
WO2008009079A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
Substituted pteridines useful for the treatment and prevention of viral infections
|
CA2657821A1
(en)
|
2006-07-21 |
2008-01-24 |
Gilead Sciences, Inc. |
Aza-peptide protease inhibitors
|
WO2008011117A2
(en)
|
2006-07-21 |
2008-01-24 |
Gilead Sciences, Inc. |
Antiviral protease inhibitors
|
SG174016A1
(en)
|
2006-07-24 |
2011-09-29 |
Korea Res Inst Chem Tech |
Hiv reverse transcriptase inhibitors
|
EP2069356A1
(en)
|
2006-07-24 |
2009-06-17 |
Gilead Sciences, Inc. |
Bisfuranyl protease inhibitors
|
CA2664156A1
(en)
|
2006-09-27 |
2008-04-03 |
Coley Pharmaceutical Group, Inc. |
Compositions of tlr ligands and antivirals
|
SI2094702T1
(sl)
|
2006-12-14 |
2016-03-31 |
Gilead Sciences, Inc. |
Virusni inhibitorji
|
US8637531B2
(en)
|
2006-12-26 |
2014-01-28 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyridmidines useful for treating viral infections
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
WO2008077649A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
US8324179B2
(en)
|
2007-02-09 |
2012-12-04 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
HUE029866T2
(en)
|
2007-02-23 |
2017-03-28 |
Gilead Sciences Inc |
Modulation of pharmacokinetic parameters of therapeutic agents
|
CN101668515B
(zh)
|
2007-03-29 |
2013-03-20 |
弗·哈夫曼-拉罗切有限公司 |
药物组合物和方法
|
US20090047252A1
(en)
|
2007-06-29 |
2009-02-19 |
Gilead Sciences, Inc. |
Antiviral compounds
|
AU2008270634B2
(en)
|
2007-06-29 |
2014-01-16 |
Gilead Sciences, Inc. |
Therapeutic compositions and the use thereof
|
EA025794B1
(ru)
|
2007-06-29 |
2017-01-30 |
Джилид Сайэнс, Инк. |
Противовирусные соединения
|
CA2692460A1
(en)
|
2007-06-29 |
2009-01-08 |
Korea Research Institute Of Chemical Technology |
Hiv reverse transcriptase inhibitors
|
KR20100041798A
(ko)
|
2007-06-29 |
2010-04-22 |
한국화학연구원 |
신규 hiv 역전사효소 억제제
|
WO2009005677A2
(en)
|
2007-06-29 |
2009-01-08 |
Gilead Sciences, Inc. |
Antiviral compounds
|
NZ582086A
(en)
|
2007-06-29 |
2012-07-27 |
Gilead Sciences Inc |
Therapeutic compositions and the use thereof
|
EA021463B1
(ru)
|
2007-06-29 |
2015-06-30 |
Джилид Сайэнс, Инк. |
Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
|
UA99466C2
(en)
|
2007-07-06 |
2012-08-27 |
Гилиад Сайенсиз, Инк. |
Crystalline pyridazine compound
|
WO2009058800A2
(en)
|
2007-10-29 |
2009-05-07 |
President And Fellows Of Harvard College |
Synthesis of nucleosides
|
CN102137676A
(zh)
|
2007-12-27 |
2011-07-27 |
伊皮芬尼生物科学公司 |
抗病毒化合物
|
PT2231628E
(pt)
|
2008-01-04 |
2015-12-29 |
Gilead Sciences Inc |
Inibidores de citocromo p450
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
AP3076A
(en)
|
2008-04-23 |
2014-12-31 |
Gilead Sciences Inc |
Carba-nucleoside analogs for antiviral treatment
|
WO2009143011A1
(en)
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
US8536187B2
(en)
|
2008-07-03 |
2013-09-17 |
Gilead Sciences, Inc. |
2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
|
PE20110219A1
(es)
|
2008-07-08 |
2011-03-31 |
Gilead Sciences Inc |
Sales del compuesto n-[(s)({[(2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il]oxi}metil)fenoxifosfinoil]-l-alaninato de etilo como inhibidores de vih
|
US7998950B2
(en)
|
2008-07-25 |
2011-08-16 |
Gilead Sciences, Inc. |
Antiviral compounds
|
PL2364314T3
(pl)
|
2008-12-09 |
2014-08-29 |
Gilead Sciences Inc |
Modulatory receptorów Toll-podobnych
|
TW201034663A
(en)
|
2008-12-19 |
2010-10-01 |
Gilead Sciences Inc |
HCV NS3 protease inhibitors
|
EP2367813A1
(en)
|
2008-12-22 |
2011-09-28 |
Gilead Sciences, Inc. |
Antiviral compounds
|
KR101834707B1
(ko)
|
2009-02-10 |
2018-03-05 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 치료를 위한 카르바-뉴클레오시드 유사체
|
TW201503888A
(zh)
|
2009-05-13 |
2015-02-01 |
Gilead Sciences Inc |
抗病毒化合物
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US20100324059A1
(en)
|
2009-06-23 |
2010-12-23 |
Gilead Sciences, Inc. |
Pharmaceutical compositions useful for treating hcv
|
TW201111381A
(en)
|
2009-06-23 |
2011-04-01 |
Gilead Sciences Inc |
Pharmaceutical combinations useful for treating HCV
|
TW201105323A
(en)
|
2009-06-23 |
2011-02-16 |
Gilead Sciences Inc |
Pharmaceutical compositions useful for treating HCV
|
US8999969B2
(en)
|
2009-07-09 |
2015-04-07 |
Gilead Sciences, Inc. |
Anti-RSV compounds
|
AP3409A
(en)
|
2009-07-21 |
2015-08-31 |
Gilead Sciences Inc |
Inhibitors of flaviviridae viruses
|
CA2771124C
(en)
|
2009-09-09 |
2019-01-15 |
Gilead Sciences, Inc. |
Inhibitors of flaviviridae viruses
|
PL2477987T3
(pl)
|
2009-09-14 |
2018-06-29 |
Gilead Sciences, Inc. |
Modulatory receptorów toll-podobnych
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
PE20120995A1
(es)
|
2009-09-21 |
2012-08-01 |
Gilead Sciences Inc |
Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral
|
KR101793300B1
(ko)
|
2009-10-22 |
2017-11-02 |
길리애드 사이언시즈, 인코포레이티드 |
특히 바이러스성 감염의 치료에 유용한 퓨린 또는 데아자퓨린의 유도체
|
WO2011079016A1
(en)
|
2009-12-22 |
2011-06-30 |
Gilead Sciences, Inc. |
Methods of treating hbv and hcv infection
|
BR112012017382A2
(pt)
|
2010-01-15 |
2017-12-05 |
Gilead Sciences Inc |
compostos inibidores de viroses flaviviridae, uso dos mesmos e composição farmacêutica
|
PT2523951E
(pt)
|
2010-01-15 |
2015-09-14 |
Gilead Sciences Inc |
Inibidores de vírus flaviviridae
|
PL2528930T3
(pl)
|
2010-01-28 |
2014-03-31 |
Riboscience Llc |
4`-azydonukleozydy jako związki przeciw hcv
|
US20110223131A1
(en)
|
2010-02-24 |
2011-09-15 |
Gilead Sciences, Inc. |
Antiviral compounds
|
UY33373A
(es)
|
2010-05-10 |
2011-12-30 |
Gilead Sciences Inc |
?Compuestos de pirazolopiridina bifuncionales, su uso en terapia y composiciones que los comprenden?.
|
CA2796826A1
(en)
|
2010-05-10 |
2011-11-17 |
Gilead Sciences, Inc. |
Bifunctional quinoline derivatives
|
WO2011146817A1
(en)
|
2010-05-21 |
2011-11-24 |
Gilead Sciences, Inc. |
Heterocyclic flaviviridae virus inhibitors
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
TW201210597A
(en)
|
2010-06-09 |
2012-03-16 |
Gilead Sciences Inc |
Inhibitors of hepatitis C virus
|
TW201211047A
(en)
|
2010-06-10 |
2012-03-16 |
Gilead Sciences Inc |
Methods for treating HCV
|
ES2551738T3
(es)
|
2010-06-11 |
2015-11-23 |
Gilead Sciences, Inc. |
Formulaciones tópicas antivirales para la prevención de la transmisión del VHS-2
|
AU2011270798B2
(en)
|
2010-06-24 |
2015-03-19 |
Gilead Sciences, Inc. |
Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
|
ES2634490T3
(es)
|
2010-07-02 |
2017-09-28 |
Gilead Sciences, Inc. |
Derivados de ácido napht-2-ylacetico para tratar el sida
|
KR20130124291A
(ko)
|
2010-07-02 |
2013-11-13 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 항바이러스 화합물로서의 2-퀴놀리닐-아세트산 유도체
|
PE20130807A1
(es)
|
2010-07-19 |
2013-07-27 |
Gilead Sciences Inc |
Metodos para la preparacion de profarmacos de fosforamidato diastereomericamente puros
|
KR101821680B1
(ko)
|
2010-07-22 |
2018-01-24 |
길리애드 사이언시즈, 인코포레이티드 |
파라믹소비리대 바이러스 감염을 치료하기 위한 방법 및 화합물
|
CN102351931B
(zh)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
NZ608070A
(en)
|
2010-09-20 |
2015-11-27 |
Gilead Sciences Inc |
2’-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
EP2640719B1
(en)
|
2010-11-17 |
2017-05-10 |
Gilead Pharmasset LLC |
Antiviral compounds
|
EP2826466A1
(en)
|
2010-11-19 |
2015-01-21 |
Gilead Sciences, Inc. |
Therapeutic compositions comprising rilpivirin hcl and tenofovir disoproxil fumarate
|
UY33775A
(es)
|
2010-12-10 |
2012-07-31 |
Gilead Sciences Inc |
Inhibidores macrocíclicos de virus flaviviridae, composiciones farmacéuticas que los comprenden y sus usos
|
WO2012087596A1
(en)
|
2010-12-20 |
2012-06-28 |
Gilead Sciences, Inc. |
Combinations for treating hcv
|
WO2012088178A1
(en)
|
2010-12-21 |
2012-06-28 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome p450 (cyp3a4)
|
US8987313B2
(en)
|
2010-12-21 |
2015-03-24 |
Gilead Sciences, Inc. |
Inhibitors of cytochrome P450
|
US20130280212A1
(en)
|
2010-12-21 |
2013-10-24 |
Gilead Sciences, Inc |
Inhibitors of cytochrome p450
|
CA2830845A1
(en)
|
2011-04-04 |
2012-10-11 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor
|
WO2012138670A1
(en)
|
2011-04-04 |
2012-10-11 |
Gilead Sciences, Inc. |
Process for the preparation of an hiv integrase inhibitor
|
EA201391264A1
(ru)
|
2011-04-13 |
2014-03-31 |
Джилид Сайэнс, Инк. |
1'-замещенные пиримидиновые n-нуклеозидные аналоги для противовирусного лечения
|
PT2699558T
(pt)
|
2011-04-21 |
2016-12-29 |
Gilead Sciences Inc |
Compostos de benzotiazole e a sua utilização farmacêutica
|
CA2836768A1
(en)
|
2011-05-02 |
2012-11-08 |
Gilead Sciences, Inc. |
Amorphous solid salts
|
CA2840095A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
MX2014000123A
(es)
|
2011-07-06 |
2014-02-17 |
Gilead Sciences Inc |
Replicones de genotipo 4 de hcv.
|
CN103687869A
(zh)
|
2011-07-06 |
2014-03-26 |
吉利德科学股份有限公司 |
Hcv基因型3复制子
|
JP5987056B2
(ja)
|
2011-07-13 |
2016-09-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
Flaviviridaeウイルスのインヒビターとして有用なチオフェン−2−カルボン酸誘導体
|
SI2744810T2
(sl)
|
2011-08-16 |
2023-11-30 |
Gilead Sciences, Inc. |
Tenofovir alafenamid hemifumarat
|
HUE036588T2
(hu)
|
2011-09-16 |
2018-07-30 |
Gilead Pharmasset Llc |
Eljárások HCV kezelésére
|
BR112014010295A2
(pt)
|
2011-10-31 |
2017-04-18 |
Gilead Pharmassett Llc |
métodos e composições para o tratamento de vírus de hepatite c
|
SG10201700947UA
(en)
|
2011-11-16 |
2017-03-30 |
Gilead Pharmasset Llc |
Condensed imidazolylimidazoles as antiviral compounds
|
BR112014012739A8
(pt)
|
2011-11-29 |
2017-06-20 |
Gilead Pharmasset Llc |
composições e métodos para o tratamento do vírus da hepatite c
|
WO2013090929A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
Amino quinoline derivatives inhibitors of hcv
|
WO2013090840A1
(en)
|
2011-12-15 |
2013-06-20 |
Gilead Sciences, Inc. |
2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors
|
US20130157973A1
(en)
|
2011-12-20 |
2013-06-20 |
Gilead Sciences, Inc. |
Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders
|
EP2794627B1
(en)
|
2011-12-22 |
2018-09-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
ES2647486T3
(es)
|
2011-12-22 |
2017-12-21 |
Gilead Sciences, Inc. |
Pirazolo[1,5-a]pirimidinas como agentes antivirales
|
WO2013103724A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
|
WO2013103738A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Napthalene acetic acid derivatives against hiv infection
|
JP2015503624A
(ja)
|
2012-01-12 |
2015-02-02 |
ギリアード サイエンシーズ, インコーポレイテッド |
医薬組成物およびその調製方法
|
WO2013115916A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Sciences, Inc. |
Combination therapy comprising gs-7340 and cobicistat for use in the treatment of viral infections
|
NZ629896A
(en)
|
2012-02-03 |
2016-03-31 |
Gilead Sciences Inc |
Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
|
US9481704B2
(en)
|
2012-03-13 |
2016-11-01 |
Gilead Sciences, Inc. |
2′-substituted carba-nucleoside analogs for antiviral treatment
|
CA2866901C
(en)
|
2012-03-21 |
2020-09-22 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
PT2838900T
(pt)
|
2012-04-17 |
2019-11-15 |
Gilead Sciences Inc |
Compostos e métodos para tratamento antiviral
|
AR090760A1
(es)
|
2012-04-20 |
2014-12-03 |
Gilead Sciences Inc |
Compuestos de benzotiazol y su uso contra el virus de hiv
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
EP2861604B1
(en)
|
2012-06-08 |
2017-03-01 |
Gilead Sciences, Inc. |
Macrocyclic inhibitors of flaviviridae viruses
|
CN104662033B
(zh)
|
2012-06-08 |
2018-10-23 |
吉利德科学公司 |
黄病毒科病毒的大环抑制剂
|
UA119315C2
(uk)
|
2012-07-03 |
2019-06-10 |
Гіліад Фармассет Елелсі |
Інгібітори вірусу гепатиту с
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
US20140094485A1
(en)
|
2012-10-03 |
2014-04-03 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor
|
CA2889171A1
(en)
|
2012-10-26 |
2014-05-01 |
Koninklijke Philips N.V. |
Autostereoscopic display device having a see-through mode of operation
|
JP2015535261A
(ja)
*
|
2012-10-29 |
2015-12-10 |
コクリスタル ファーマ,インコーポレイテッド |
ウイルス感染及び癌の治療のためのピリミジンヌクレオチド及びその一リン酸プロドラッグ
|
CN104755501A
(zh)
|
2012-10-30 |
2015-07-01 |
吉联亚科学公司 |
与赖氨酰氧化酶样蛋白2(loxl2)相关的治疗和诊断方法
|
WO2014074620A1
(en)
|
2012-11-07 |
2014-05-15 |
Gilead Sciences, Inc. |
Hcv genotype 6 replicons
|
US9211300B2
(en)
|
2012-12-19 |
2015-12-15 |
Idenix Pharmaceuticals Llc |
4′-fluoro nucleosides for the treatment of HCV
|
KR102327888B1
(ko)
|
2012-12-21 |
2021-11-17 |
얀센 바이오파마, 인코퍼레이트. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
|
RS54873B1
(sr)
|
2012-12-21 |
2016-10-31 |
Gilead Sciences |
Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
PT2943487T
(pt)
|
2013-01-09 |
2016-12-15 |
Gilead Sciences Inc |
Heteroarilos de 5 membros e sua utilização como agentes antivirais
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
PL2943493T3
(pl)
|
2013-01-09 |
2017-12-29 |
Gilead Sciences, Inc. |
Związki terapeutyczne do leczenia zakażeń wirusowych
|
WO2014124430A1
(en)
|
2013-02-11 |
2014-08-14 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
TWI706945B
(zh)
|
2013-03-01 |
2020-10-11 |
美商基利科學股份有限公司 |
供治療反轉錄病毒科病毒感染之治療性化合物
|
EP2970335B1
(en)
|
2013-03-15 |
2019-05-08 |
Gilead Sciences, Inc. |
Macrocyclic and bicyclic inhibitors of hepatitis c virus
|
US20140273023A1
(en)
|
2013-03-15 |
2014-09-18 |
Saladax Biomedical Inc. |
Gemcitabine immunoassay
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
US9447132B2
(en)
|
2013-04-12 |
2016-09-20 |
Achillion Pharmaceuticals, Inc. |
Highly active nucleoside derivative for the treatment of HCV
|
MA38675A1
(fr)
|
2013-05-16 |
2017-12-29 |
Riboscience Llc |
Dérivés de nucléosides 4'-fluoro-2'-méthyle substitués utiles pour inhiber la replication de l'hepatite c (hcv)
|
CA2913206C
(en)
|
2013-06-26 |
2022-08-02 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US20150072418A1
(en)
|
2013-08-16 |
2015-03-12 |
Gilead Sciences, Inc. |
Hcv genotype 4d replicons
|
SI3043803T1
(sl)
|
2013-09-11 |
2022-09-30 |
Emory University |
Nukleotidne in nukleozidne sestave in njihova uporaba
|
CN105829333A
(zh)
|
2013-10-11 |
2016-08-03 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
US20150150897A1
(en)
|
2013-12-02 |
2015-06-04 |
Gilead Pharmasset Llc |
Methods of treating hepatitis c virus infection in subjects with cirrhosis
|
US9562058B2
(en)
|
2013-12-23 |
2017-02-07 |
Gilead Sciences, Inc. |
Crystalline forms of an antiviral compound
|
TW201609785A
(zh)
|
2013-12-23 |
2016-03-16 |
吉李德製藥公司 |
固體型之抗病毒化合物
|
TWI660965B
(zh)
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
EP3613418A1
(en)
|
2014-01-17 |
2020-02-26 |
Ligand Pharmaceuticals, Inc. |
Methods and compositions for modulating hormone levels
|
WO2015120057A1
(en)
|
2014-02-05 |
2015-08-13 |
Gilead Sciences, Inc. |
Pharmaceutical combinations against co-infection with hiv and tuberculosis
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
WO2015130966A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Antiviral agents
|
WO2015179448A1
(en)
|
2014-05-21 |
2015-11-26 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
US20150361087A1
(en)
|
2014-06-12 |
2015-12-17 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US9499523B2
(en)
|
2014-06-13 |
2016-11-22 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|
KR20170010063A
(ko)
|
2014-06-13 |
2017-01-25 |
길리애드 사이언시즈, 인코포레이티드 |
포스파티딜이노시톨 3-키나제 억제제
|
NZ726360A
(en)
|
2014-06-13 |
2018-04-27 |
Gilead Sciences Inc |
Phosphatidylinositol 3-kinase inhibitors
|
CA2952018A1
(en)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences, Inc. |
Quinazolinone derivatives as phosphatidylinositol 3-kinase inhibitors
|
MX2016016516A
(es)
|
2014-06-13 |
2017-05-01 |
Gilead Sciences Inc |
Inhibidores de fosfatidilinositol 3-cinasa.
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
EP3160475B1
(en)
|
2014-06-24 |
2024-01-03 |
Janssen Pharmaceuticals, Inc. |
Substituted nucleosides and nucleotides to treat filoviridae infections
|
CN106573011A
(zh)
|
2014-06-24 |
2017-04-19 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸和其类似物
|
CN105288635A
(zh)
|
2014-06-26 |
2016-02-03 |
昆明积大制药股份有限公司 |
一种含有阿糖胞苷5’-0-氨基酸酯的药物组合物
|
KR102019572B1
(ko)
|
2014-07-11 |
2019-09-06 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 치료를 위한 톨-유사 수용체의 조정제
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2’-氯胺基嘧啶酮及嘧啶二酮核苷類
|
CA2958742C
(en)
|
2014-08-29 |
2019-04-30 |
Gilead Sciences, Inc. |
Antiretroviral agents
|
WO2016036759A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
EP3034499A1
(en)
|
2014-12-17 |
2016-06-22 |
Gilead Sciences, Inc. |
Novel FXR (NR1H4) modulating compounds
|
TWI695003B
(zh)
|
2014-12-23 |
2020-06-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
EA201791304A1
(ru)
|
2014-12-24 |
2017-12-29 |
Джилид Сайэнс, Инк. |
Производные изохинолина для лечения вич
|
TW202237569A
(zh)
|
2014-12-24 |
2022-10-01 |
美商基利科學股份有限公司 |
喹唑啉化合物
|
SG11201705192PA
(en)
|
2014-12-24 |
2017-07-28 |
Gilead Sciences Inc |
Fused pyrimidine compounds for the treatment of hiv
|
CA2972259A1
(en)
|
2014-12-26 |
2016-06-30 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
WO2016134054A1
(en)
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Anti-viral compounds
|
DK3097102T3
(en)
|
2015-03-04 |
2018-01-22 |
Gilead Sciences Inc |
TOLL-LIKE RECEPTOR MODULATING 4,6-DIAMINO-PYRIDO [3,2-D] PYRIMIDINE COMPOUNDS
|
EP3466490B1
(en)
|
2015-04-02 |
2020-10-21 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
CA2981856A1
(en)
|
2015-04-14 |
2016-10-20 |
Gilead Sciences, Inc. |
Methods of treating hepatitis b virus
|
CN107849024A
(zh)
|
2015-05-15 |
2018-03-27 |
吉利德科学公司 |
具有作为吲哚胺2,3‑二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物
|
JP2018524308A
(ja)
|
2015-06-17 |
2018-08-30 |
ギリアード サイエンシーズ, インコーポレイテッド |
テノホビルアラフェナミドの共結晶、塩および結晶形態
|
CA2921336A1
(en)
|
2015-06-30 |
2016-12-30 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
EP4233846A3
(en)
|
2015-06-30 |
2023-10-04 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
WO2017024310A1
(en)
|
2015-08-06 |
2017-02-09 |
Chimerix, Inc. |
Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents
|
JP2018525412A
(ja)
|
2015-08-26 |
2018-09-06 |
ギリアード サイエンシーズ, インコーポレイテッド |
重水素化トール様受容体調節因子
|
WO2017040895A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral compounds
|
WO2017040896A1
(en)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Anti-viral compounds
|
EP3349757A1
(en)
|
2015-09-15 |
2018-07-25 |
Gilead Sciences, Inc. |
Modulators of toll-like recptors for the treatment of hiv
|
MA52371A
(fr)
|
2015-09-16 |
2021-09-22 |
Gilead Sciences Inc |
Méthodes de traitement d'infections dues aux coronaviridae
|
EP3356355B1
(en)
|
2015-09-30 |
2020-05-13 |
Gilead Sciences, Inc. |
Compounds and combinations for the treatment of hiv
|
ES2900482T3
(es)
|
2015-10-01 |
2022-03-17 |
Gilead Sciences Inc |
Combinación de un inhibidor de Btk y un inhibidor de punto de control para el tratamiento del cáncer
|
CN108348473B
(zh)
|
2015-11-09 |
2021-06-18 |
吉利德科学公司 |
治疗人免疫缺陷病毒的治疗组合物
|
CU20180062A7
(es)
|
2015-12-15 |
2018-08-06 |
Gilead Sciences Inc |
Anticuerpos neutralizadores del virus de inmunodeficiencia humana
|
EP3394044A1
(en)
|
2015-12-17 |
2018-10-31 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
WO2017156380A1
(en)
*
|
2016-03-10 |
2017-09-14 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
US11963972B2
(en)
*
|
2016-03-23 |
2024-04-23 |
Emory University |
Antiviral agents and nucleoside analogs for treatment of Zika virus
|
ES2796488T3
(es)
|
2016-04-08 |
2020-11-27 |
Krystal Biotech Inc |
Composiciones para el uso en métodos para el tratamiento de heridas, trastornos y enfermedades de la piel
|
WO2017184668A1
(en)
|
2016-04-20 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating flaviviridae virus infections
|
WO2017184670A2
(en)
|
2016-04-22 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating zika virus infections
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
CA3025633C
(en)
|
2016-05-27 |
2021-02-23 |
Gilead Sciences, Inc. |
Methods for treating hepatitis b virus infections using ns5a, ns5b or ns3 inhibitors
|
EP3471738A4
(en)
|
2016-06-20 |
2020-01-01 |
Merck Sharp & Dohme Corp. |
PHOSPHATE-SUBSTITUTED CYCLIC NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
|
WO2017223268A1
(en)
|
2016-06-22 |
2017-12-28 |
Yale University |
COMPOSITIONS AND METHODS OF RESENSITIZING CELLS TO BROMODOMAIN AND EXTRATERMINAL DOMAIN PROTEIN INHIBITORS (BETi)
|
RU2020116571A
(ru)
|
2017-12-07 |
2021-11-22 |
Эмори Юниверсити |
N4-гидроксицитидин и производные и связанные с этим противовирусные применения
|
BR112020018209A2
(pt)
|
2018-03-07 |
2020-12-29 |
Emory University |
Composições farmacêuticas, recipiente pressurizado, e, métodos para tratar ou prevenir uma infecção viral e para tratar ou prevenir um coronavírus humano, coronavírus sars, coronavírus mers, vírus da encefalite equina oriental, vírus da encefalite equina ocidental, vírus da encefalite equina venezuelana, vírus da chicungunha, vírus ross river, rsv, vírus influenza a, vírus influenza b, vírus tacaribe, vírus pichinde, vírus junin, vírus da febre lassa, vírus da cariomeningite linfocitária, vírus da febre rift valley, vírus punta toro, vírus lacrosse, vírus maporal, vírus heartland, e vírus da síndrome de trombocitopenia de febre severa, poliovírus, vírus de coxsackie, infecção de norovírus ou enterovírus em um paciente
|
AU2021216049A1
(en)
|
2020-02-07 |
2022-08-18 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|